Your search is "CD3" and there are 55 results
【Immune checkpoints】NFAT
产品中心 > Cell lines > Immune checkpoints
【TAA】TNFRSF8(CD30)
产品中心 > Cell lines > TAA
【Antibody function】ADCC
产品中心 > Cell lines > Antibody function
【Antibody function】FcγR
产品中心 > Cell lines > Antibody function
【Antibody function】Jurkat NFAT
产品中心 > Cell lines > Antibody function
【Immunotherapy target】CD3
产品中心 > Cell lines > Immunotherapy target
【Immune checkpoints】CD33(SIGLEC3)
产品中心 > Cell lines > Immune checkpoints
【Biosimilar Antibodies】TAA
产品中心 > Antibodies > Biosimilar Antibodies
【Biosimilar Antibodies】Immunotherapy target
产品中心 > Antibodies > Biosimilar Antibodies
【TAA】CD38
产品中心 > Cell lines > TAA
【Biosimilar Antibodies】Bispecific Antibody
产品中心 > Antibodies > Biosimilar Antibodies
【Insights】CD38: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
2024-09-23
【Insights】CD19/CD20/CD3:GSK enters agreement to acquire CMG1A46 from Chimagen Bioscience
2024-11-01
【Insights】AstraZeneca Announces Data from First-in-Human Phase 1 Study of AZD0486, a Novel CD19xCD3 T-Cell Activator, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2024-11-08
【产品中心】CD3-CD2-tsAb Reporter Jurkat(CD58 KO) Cell Line
产品中心
【产品中心】H_CD3D CD3E KO Jurkat Cell Line
产品中心
【产品中心】ADCC FcγRIIIa(158V) Reporter Jurkat(CD3 KO) Cell Line
产品中心
【产品中心】Mouse_CD3 HEK-293 Cell Line
产品中心
【产品中心】H_CD3 CHO-K1 Cell Line
产品中心
【产品中心】H_TNFRSF8(CD30) MC38 Cell Line
产品中心
First 1 2 3 Last
Total 3 Page
Jump
More
Message consultation
reset
submit
Message
Message consultation
reset
submit